New Bethesda terminology and evidence-based management guidelines for cervical cytology findings

JAMA

Volumn 287, Issue 16, 2002, Pages 2140-2141

  Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DNA DETERMINATION; EDITORIAL; EVIDENCE BASED MEDICINE; NOMENCLATURE; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VALIDATION PROCESS;

EID: 0037165741     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.16.2140     Document Type: Editorial

References (10)

1. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
2. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study
3. Qualification of ASCUS: A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS-LSIL Triage Study
4. HPV testing for colposcopy triage: Data on viral load and age effects from the ASCUS- LSIL Triage Study (ALTS)
5. The 2001 Bethesda System: Terminology for reporting results of cervical cytology
6. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities
7. Consequences of eliminating ASCUS
8. Atypical glandular cells of undetermined significance (AGUS): A five-year retrospective histopathologic study
9. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection
10. Interim guidelines for management of abnormal cervical cytology: The 1992 National Cancer Institute workshop